tiprankstipranks
Trending News
More News >
Parnell Pharmaceuticals Holdings (PARNF)
OTHER OTC:PARNF
US Market

Parnell Pharmaceuticals (PARNF) Income Statement

Compare
16 Followers

Parnell Pharmaceuticals Income Statement

See PARNF’s key income statement, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18
Total Revenue
AU$ 34.17MAU$ 30.00MAU$ 28.99MAU$ 26.55M
Gross Profit
AU$ 19.26MAU$ 17.52MAU$ 17.39MAU$ 15.52M
Operating Expenses
AU$ 17.92MAU$ 20.84MAU$ 16.95MAU$ 12.10M
Depreciation and Amortization
AU$ 1.82MAU$ 450.99KAU$ 1.04MAU$ 2.65M
EBITDA
AU$ 6.00MAU$ 4.23MAU$ 2.40MAU$ 5.26M
Operating Income
AU$ 1.35MAU$ 3.78MAU$ 1.36MAU$ 2.61M
Other Income/Expenses
AU$ -2.77MAU$ -17.02MAU$ -6.92MAU$ -3.08M
Pretax Income
AU$ -1.42MAU$ -15.05MAU$ -6.95MAU$ 337.04K
Net Income
AU$ -1.42MAU$ -15.06MAU$ -7.18MAU$ 129.62K
Per Share Metrics
Basic EPS
AU$ -0.05AU$ -0.81AU$ -0.40AU$ 0.00
Diluted EPS
AU$ -0.05AU$ -0.81AU$ -0.40AU$ 0.00
Weighted Average Shares Outstanding
28.96M 18.55M 18.02M 0.00
Weighted Average Shares Outstanding (Diluted)
28.96M 18.55M 18.02M 0.00
Currency in AUD

Parnell Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis